ArticleJournal of experimental & clinical cancer research : CR2018

MiR-760 suppresses human colorectal cancer growth by targeting BATF3/AP-1/cyclinD1 signaling.

Ling Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.